Cargando…
Bleomycin‐induced pulmonary toxicity and treatment with infliximab: A case report
Given the current understanding of bleomycin‐induced pneumonitis (BIP), the use of tumor necrosis factor alpha (TNF‐α) inhibitors such as infliximab for late‐stage disease appears to be of limited benefit. Further research regarding prevention and management of advanced BIP is required.
Autores principales: | Ge, Victor, Banakh, Iouri, Tiruvoipati, Ravindranath, Haji, Kavi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186889/ https://www.ncbi.nlm.nih.gov/pubmed/30349718 http://dx.doi.org/10.1002/ccr3.1790 |
Ejemplares similares
-
Imatinib for bleomycin induced pulmonary toxicity: a case report and evidence‐base review
por: Banakh, Iouri, et al.
Publicado: (2016) -
Prolonged encephalopathy and associated nonconvulsive seizures from suspected pregabalin and tapentadol: Two case reports and review of literature
por: Haji, Kavi, et al.
Publicado: (2021) -
Severe Rhabdomyolysis due to Presumed Drug Interactions between Atorvastatin with Amlodipine and Ticagrelor
por: Banakh, Iouri, et al.
Publicado: (2017) -
Meropenem-induced vanishing bile duct syndrome: A case report
por: Zubarev, Alexandr, et al.
Publicado: (2020) -
Euglycemic diabetic ketoacidosis in association with dapagliflozin use after gastric sleeve surgery in a patient with type II diabetes mellitus
por: Banakh, Iouri, et al.
Publicado: (2019)